Allianz Asset Management’s Korro Bio KRRO Stock Holding History

Allianz Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,532	Closed	-$1.78M	–	2152
2020 Q2	$1.78M	Buy	+1,532	New	+$1.38M	﹤0.01%	1654

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Mizuho Securities Tokyo, Japan $7.68M AUM 15.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's KRRO Position: Q3 2020 in Review

Allianz Asset Management sold out of Korro Bio (KRRO) in Q3 2020, closing a stake of 1,532 shares — an estimated $1.78M sold.

Allianz Asset Management first reported a position in KRRO in Q2 2020 and held it in 1 quarter. The position peaked at $1.78M in Q2 2020. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2020.

Allianz Asset Management reported no remaining Korro Bio position as of Q3 2020 after selling out during the quarter.
Allianz Asset Management sold 1,532 Korro Bio shares in Q3 2020, an estimated $1.78M.
Allianz Asset Management first reported a position in Korro Bio in Q2 2020 and held it in 1 quarter.
Allianz Asset Management's Korro Bio position peaked at $1.78M in Q2 2020.
71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2020.

Based on Allianz Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.